| Business Summary | | Pharmaceutical
Formulations,
Inc.
is
primarily
engaged
in
the
manufacture
and
distribution
of
non-prescription
or
over-the-counter
(OTC)
solid-dose
pharmaceutical
products.
Such
products,
which
are
made
in
tablet,
caplet
or
capsule
form,
are
primarily
sold
under
its
customers'
store
brands
or
other
private
labels,
manufactured
under
contract
for
national
brand
pharmaceutical
companies,
or
sold
in
bulk
to
others
who
repackage
them
for
sale
to
small,
typically
independent,
retailers
and
to
other
manufacturers
who
do
not
have
government
approval
to
manufacture
certain
formulas.
The
Company
sells
and
markets
a
line
of
antifungal
aerosols
and
also
sells
generic
OTC
products
under
its
own
brand
names,
including
HEALTH+CROSS
and
HEALTH
PHARM. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Pharmaceutical
Formulations
engages
in
the
manufacture
and
distribution
of
OTC
pharmaceuticals
sold
under
customers'
private
labels,
and
sells
generic
OTC
products.
For
the
nine
months
ended
3/31/01,
net
sales
fell
41%
to
$36.9
million.
Net
loss
applicable
to
Common
totaled
$8.9
million
vs.
an
income
of
$490
thousand.
Results
reflect
the
production
and
shippment
problems
and
other
difficulties
experienced
during
the
installation
of
the
new
computer
system. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY2000 Pay | |
| John Oram, 56 Chairman | -- | James Ingram, 59 Pres,
COO, Director | -- | R. Bradley Conner, 54 CFO,
VP, Treasurer, Controller | -- | Ward Barney, 49 VP,
Operations | $186K | Susan Baer, 49 VP,
Gen. Counsel, Sec. | 106K | Dollar amounts are as of 1-July-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|